This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medco, Toll Brothers, Tyco Hit 52-Week Highs

NEW YORK ( TheStreet) -- Shares of Medco Health Solutions (MHS), Toll Brothers (TOL - Get Report) and Tyco International (TYC - Get Report) hit 52-week highs on Wednesday.

Medco Health Solutions

The health care company's acquisition by pharmacy benefit manager Express Scripts (ESRX) is expected to be ruled on by the Federal Trade Commission as soon as Friday, according to Bloomberg.

"Express Scripts ESRX and Medco MHS announced Wednesday that they may be able to close their merger as soon as next week," Morningstar analysts wrote in a report on Wednesday. "As we previously indicated, we plan to raise our fair value estimate for Express Scripts to $73 and for Medco to $88. We believe the merger has the potential to create significant revenue and cost synergies."

Shares of Medco hit a 52-week high Wednesday of $72.50. The stock's 52-week low of $44.60 was set on Oct. 4.

Medco has an estimated price-to-earnings ratio for next year of 14.95 times; the average for health care providers is 17.78. For comparison, Cigna (CI) has a lower forward P/E of 7.79 times; Express Scripts' forward P/E is 13.01.

Thirteen of the 20 analysts who cover Medco rated it hold. Six analysts gave the stock a buy rating and one rated it sell.

TheStreet Ratings gives Medco a B grade with a buy rating and a $79.51 price target. The stock has risen 27.67% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MHS $70.30 0.00%
TYC $34.10 -1.59%
TOL $25.12 0.28%
AAPL $94.27 -0.76%
FB $101.00 1.47%


Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs